Clinical Trial Update: Fecal Microbiota Transplant for Primary CDI [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating fecal microbiota transplant for primary Clostridium difficile infection has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Boston Medical Center | Conditions: Clostridium Difficile Infection | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-12-15